Results provide a mechanistic explanation of why early loss of p53 signaling is frequently observed in UC-associated ...

A team of researchers led by Kimberly Hartl, a graduate student at the Berlin Institute for Medical Systems Biology of the ...

Researchers in the lab of Michael Sigal at the Max Delbrück Center and Charité – Universitätsmedizin Berlin have elucidated ...

Researchers have elucidated the role of the p53 gene in ulcerative colitis. The study suggests a potential new drug target to stop disease progression to cancer.

New research highlights a pivotal role for the p53 gene in ulcerative colitis progression, offering a potential therapeutic ...

The findings offer a promising drug target to prevent progression to colon cancer by targeting abnormal cells early on.

In a recent perspective published in the journal Cell Death and Differentiation, researchers in France, Germany, and Sweden ...